Can Vaccine Development Weather Political Storms? The vaccine development landscape faces significant headwinds as political decisions increasingly influence scientific processes and public health initiatives. Recent shifts in regulatory approaches and …
Tag:
Pharma
-
-
FDA Approves First Generic Versions of Farxiga (Dapagliflozin) In a significant move for patient access and healthcare affordability, the U.S. Food and Drug Administration (FDA) approved the first generic versions …
-
AbbVie Brings Humira to TrumpRx with Significant Price Reductions In a major shift for pharmaceutical pricing in the U.S., AbbVie has integrated its blockbuster drug Humira into the government’s direct-to-consumer …
-
FDA Approves Relacorilant Combination Therapy for Platinum-Resistant Ovarian Cancer On March 25, 2026, the Food and Drug Administration (FDA) approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a first-in-class selective glucocorticoid receptor …
-
BörsenNEWS.de: A Comprehensive Overview BörsenNEWS.de is a leading German-language financial portal catering primarily to private investors. Founded and operated by Markets Inside Media GmbH in Leipzig, the platform provides a …
-
Next-Generation Weight-Loss Drugs Show Promise in Clinical Trials The landscape of weight-loss medication is rapidly evolving, with new drugs demonstrating significant results in clinical trials. Eli Lilly’s retatrutide, a next-generation …
-
China Approves First Commercially Available Brain-Computer Interface China has taken a significant step forward in neurotechnology, granting commercial approval for the country’s first brain-computer interface (BCI) device. Developed by Shanghai-based …
-
The Complex Relationship Between Natural Remedies and Modern Medicine Online, a compelling narrative is gaining traction: that “Huge Pharma” deliberately suppresses powerful, inexpensive natural remedies in favor of costly medications. …
-
BOSTON—Tobor, in its gray outfit, had been showing off its nimble limbic moves, as if dancing. It quickly became the buzz at the 2026 Society for Laboratory Automation and Screening …
-
Eli Lilly’s Weight Loss Drug Shows Promise, But Medicare Negotiations Loom Large Table of Contents Eli Lilly’s Weight Loss Drug Shows Promise, But Medicare Negotiations Loom Large Orforglipron: A Potential …
Newer Posts